Nihon Kohden (OTCMKTS:NHNKY) Sets New 12-Month Low – Here’s Why

Posted by Trevor Kearing on Jun 9th, 2026

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $8.70 and last traded at $8.70, with a volume of 4499 shares traded. The stock had previously closed at $8.76.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

View Our Latest Analysis on Nihon Kohden

Nihon Kohden Price Performance

The company has a market cap of $1.47 billion, a P/E ratio of 14.56 and a beta of 0.40. The firm’s 50-day moving average is $9.31 and its two-hundred day moving average is $10.22.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%. The business had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. As a group, sell-side analysts expect that Nihon Kohden Corporation will post 0.61 EPS for the current year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.